Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220018217 220009725 null null Palliative (P) 2012-02-29 2013-07-19 ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE + MELPHALAN N N 220020796 LENALIDOMIDE
220018219 220009729 1.7 57.1 Palliative (P) 2015-01-04 2015-01-13 Busulfan + Cyclophos Conditioning N N 220021070 ALL INTERIM GUIDELINES
220018220 220009731 1.67 66.95 Palliative (P) 2018-01-20 2018-01-21 Sorafenib N null 220021563 LENALIDOMIDE
220018221 220009733 null 103 Palliative (P) 2017-02-07 2017-09-21 BENDAMUSTINE + RITUXIMAB N Y 220021657 OSIMERTINIB
220018222 220015132 1.8 67.5 Palliative (P) 2014-06-12 2014-06-25 CISPLATIN + RT N N 220021758 DABRAFENIB
220018223 220015133 null 65.8 Palliative (P) 2016-11-28 2017-09-25 Ipilimumab N N 220021916 PERTUZUMAB + TRASTUZUMAB
220018224 220015133 1.8 106.2 Palliative (P) 2019-04-07 2019-06-15 MA (Cytarabine 3g/m2) 02 N 220021916 ARSENIC TRIOXIDE + ATRA
220018225 220009740 1.74 66 Neo-adjuvant (N) 2015-01-15 2015-01-17 Ipilimumab 2 N 220022309 PEMBROLIZUMAB
220018226 220009742 null 70 Palliative (P) 2018-11-26 2018-11-26 Bevacizumab+Carbo+Pacliaxel N null 220022614 NHL 2003
220018227 220021034 1.65 0 Neo-adjuvant (N) 2014-10-15 2015-01-06 ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE 02 N 220022881 CARBOPLATIN
220018228 220009748 1.8 102.2 Palliative (P) 2015-06-29 2015-07-29 INTERFERON 02 Y 220023457 INTERFERON
220018229 220009750 null 97 Disease modification (D) 2016-07-11 2016-08-09 Arsenic Triox + Tretinoin Ind W1-4 N N 220023979 VINORELBINE
220018230 220009751 null null Disease modification (D) 2014-07-02 2014-08-09 MidAC Y N 220024165 ALEMTUZUMAB + CYCLO + FLUDARABINE
220018231 220009753 1.62 0 null 2014-08-14 2014-08-18 Everolimus 10mg N N 220025845 CVAD
220018232 220009756 1.9 0 null 2018-10-01 2018-11-15 Arsenic Triox + Tretinoin Ind W1-4 N N 220026216 TRASTUZUMAB
220018233 220009758 1.49 68.7 Palliative (P) 2017-08-10 2017-08-19 FIGARO TRIAL N N 220026615 VINORELBINE
220018234 220009759 1.63 125 Curative (C) 2018-03-11 2018-11-07 CYTARABINE + MITOXANTRONE N N 220026657 VIOLA TRIAL
220018235 220018253 1.75 80.3 Disease modification (D) 2018-03-27 2018-03-29 CISPLATIN + FLUOROURACIL N N 220027021 VENETOCLAX
220018236 220015140 0 79.3 Curative (C) 2018-06-10 2018-08-12 CISPLATIN + FLUOROURACIL N N 220027282 CLADRIBINE
220018237 220015141 null 100 null 2015-12-11 2015-12-15 CETUXIMAB null null 220027517 UKALL2011
220018238 220009765 1.83 51 Curative (C) 2017-02-11 2017-03-06 GEMCITABINE + OXALIPLATIN + PACLITAXEL N null 220027666 MYELOMA XI TRIAL
220018239 220015142 1.75 83.3 Palliative (P) 2018-07-26 2018-07-26 MERCAPTOPURINE + METHOTREXATE 01 N 220027990 CYTARABINE + MITOXANTRONE
220018240 220009768 1.56 78.4 Curative (C) 2017-05-01 2017-05-15 Cetuximab 7 day (Cycle 1) N N 220028693 CARBOPLATIN + IRINOTECAN
220018241 220020013 1.72 68.45 null 2018-05-22 2018-05-29 MITOXANTRONE + TRETINOIN 01 N 220028838 FIGARO TRIAL
220018242 220009772 null null Curative (C) null 2018-04-19 Cytarabine+Methotrexate Intrathecal 02 null 220029150 MITOXANTRONE + TRETINOIN
220018243 220009773 1.67 67.5 Palliative (P) 2019-04-12 2019-04-13 Dacarbazine 02 null 220029686 FLUOROURACIL
220018244 220009776 1.51 47.6 Curative (C) 2017-06-26 2017-07-18 Capecitabine N N 220029716 CAPECITABINE
220018245 220015150 1.67 80 Curative (C) 2017-10-30 2017-11-08 DACTINOMYCIN 2 N 220031025 ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE
220018246 220021037 1.71 74 Curative (C) null 2017-09-11 Cisplatin N N 220031271 LENALIDOMIDE
220018247 220009779 1.75 64.3 Palliative (P) 2017-05-04 2017-05-05 Alemtuzumab + Cyclophos TBI Allo N N 220031497 DABRAFENIB + TRAMETINIB
220018248 220009781 null null null 2014-08-06 2014-08-12 MACE N null 220031627 ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE
220018249 220009782 1.36 28.5 null 2017-06-06 2017-10-24 Carboplatin AUC 6 - 10 N Y 220032124 MITOXANTRONE + TRETINOIN
220018250 220009784 1.49 62.2 Curative (C) 2018-07-10 2018-07-30 Sorafenib 01 N 220032395 TRABECTEDIN
220018251 220009788 1.75 64.3 Curative (C) 2016-05-26 2016-07-27 VINORELBINE N N 220032898 TOPOTECAN
220018252 220018262 1.64 118.1 Palliative (P) 2015-04-21 2015-09-13 BUSULFAN + CYCLO 2 N 220033588 GEMCITABINE
220018253 220021931 1.64 8.9 Disease modification (D) null 2017-01-29 ALL UKALL2003 TRIAL 02 N 220033707 MITOXANTRONE + TRETINOIN
220018254 220009791 1.53 64.1 Curative (C) null 2013-09-15 Carboplatin AUC 6 - 10 null null 220033759 FCR
220018255 220009792 1.68 76 Curative (C) 2018-05-15 2018-06-03 SPANISH MAINTENANCE 2 N 220034024 FLA
220018256 220009794 1.77 68 Curative (C) 2013-08-02 2013-11-08 MITOXANTRONE + TRETINOIN N N 220034048 TRASTUZUMAB
220018257 220015162 1.72 null Adjuvant (A) 2019-01-04 2019-06-26 Sorafenib null null 220034188 NHL 2003
220018258 220009800 null 94.2 Palliative (P) 2018-08-13 2018-08-16 Capecitabine + Oxaliplatin 14day N N 220034318 IPILIMUMAB
220018259 220009803 1.69 null Curative (C) 2014-08-12 2014-08-12 CYTARABINE + Vosaroxin N null 220034508 MACE
220018260 220009809 1.91 null Curative (C) 2018-03-21 2018-03-21 Cytarabine+Methotrexate Intrathecal null null 220034781 CYCLOPHOSPHAMIDE + ETOPOSIDE HD
220018261 220015163 1.8 68.45 Curative (C) null 2018-08-06 RAVVA TRIAL null N 220034831 CYCLOPHOSPHAMIDE HIGH DOSE
220018262 220009812 1.8 91.6 null 2017-05-24 2017-05-24 BENDAMUSTINE + RITUXIMAB 2 Y 220035216 CISPLATIN + RT
220018263 220009815 1.81 89.4 Curative (C) 2015-05-26 2015-07-16 Cisplatin 2 N 220035338 LENALIDOMIDE
220018264 220015166 1.62 48 Disease modification (D) 2014-10-20 2014-10-21 Carboplatin + Docetaxel Y N 220035346 CARBOPLATIN + DOCETAXEL
220018265 220009818 1.44 null null 2012-11-10 2013-11-07 FIGARO TRIAL N null 220035438 ABVD
220018266 220009819 1.69 null null null 2013-08-24 FIGARO TRIAL null null 220035628 MYELOMA XI TRIAL
220018267 220009822 1.7 0 Curative (C) 2015-03-03 2015-03-05 Mercaptopurine N N 220020987 MERCAPTOPURINE